sponsored
PatientsVille.com Logo

PatientsVille

Erectile Dysfunction Medical Research Studies

Up-to-date List of Erectile Dysfunction Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Erectile Dysfunction Medical Research Studies

Rank Status Study
1 Unknown  Treatment of Erectile Dysfunction in Hypogonadal Men With Testosterone Undecanoate
Conditions: Erectile Dysfunction;   Hypogonadotrophic Males
Intervention: Drug: Testosterone Undecanoate and/or PDE-5
Outcome Measures: Score higher than or equal to 21 of the Erectile Dysfunction domain of the IIEF, or response to treatment;   and/or an affirmative response to the GAQ will be considered for the analysis
2 Unknown  A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies
Condition: Erectile Dysfunction
Interventions: Drug: Sildenafil Citrate 20mg Tablet Sublingual;   Drug: Viagra ® 50mg tablet Coated
Outcome Measures: Evaluate a possible superiority expressed by the faster onset of action.;   Evaluate the efficacy and tolerability of Sildenafil Citrate 20mg Sublingual tablet, compared to Viagra ® 50mg tablet Coated in control of Erectile Dysfunction.
3 Recruiting Prevalence Of Internal Pudendal Artery Disease In Patients With Erectile Dysfunction Undergoing Diagnostic Coronary Angiography
Condition: To Assess the Presence of Internal Pudendal Artery Disease in Patients With Erectile Dysfunction Undergoing Coronary Angiography
Intervention:
Outcome Measure: To assess the presence of internal pudendal artery disease in patients with Erectile Dysfunction undergoing coronary angiography
4 Recruiting Assessment of Penile Vibratory Stimulation Using the Viberect in Men With Mild-Moderate and No Erectile Dysfunction
Condition: Organic Erectile Dysfunction
Intervention: Device: Viberect
Outcome Measures: To assess daily or on-demand ease of use, and efficacy of the home use of the Viberect device by men with mild to moderate and no Erectile Dysfunction;   To assess safety of using Viberect penile stiumulation for the treatment of mild-moderate ED
5 Unknown  The Prevalence of Erectile Dysfunction (ED) and ED Related Quality of Life of Diabetic Men
Conditions: Diabetes;   Erectile Dysfunction
Intervention:
Outcome Measure:
6 Recruiting Imaging and Interventional Study for Erectile Dysfunction and Lower Urinary Tract Symptoms
Conditions: Erectile Dysfunction;   Lower Urinary Tract Symptoms;   Peripheral Arterial Disease
Interventions: Device: drug-eluting balloon;   Device: biodegradable vascular scaffold stent;   Device: Apex™ PTCA Dilatation Catheter;   Device: Stent System
Outcome Measures: IIEF;   EPS;   IPSS;   CT angiographic binary restenosis
7 Recruiting Autologous Adipose-Derived Stromal Cells Delivered Into the Corpus Cavernous in Patients With Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Other: Liposuction;   Other: Stem Cell Injection
Outcome Measures: Change from Baseline in Schramek's Grade;   Change from Baseline of Penile Doppler;   Improvement in Phallometry Measures
8 Unknown  Double Blind Placebo Controlled Study on the Effect of Extracorporal Shock Wave Therapy on Erectile Dysfunction in PDE5i Responders
Condition: Erectile Dysfunction
Intervention: Device: "MEDISPEC" treatment probe
Outcome Measures: International Index of Erectile function- Erectile Function Domain;   Rigidity scale;   Flow Mediated Dilatation Technique
9 Recruiting Evaluate the Use of Liposuction and Cell Separation Devices for Autologous Fat (Adipose) Derived Cells to Treat the Symptoms of Erectile Dysfunction
Condition: Erectile Dysfunction
Intervention: Device: Tissue Genesis Cell Isolation System
Outcome Measures: Adverse Events that occur during or after the procedure to measure safety and tolerability;   Erectile function;   Continence;   Treatment assessment;   Erection hardness
10 Unknown  Low Intensity Shock Wave Therapy (LI-ESWT) for Erectile Dysfunction in Post Radical Prostatectomy Patients Not Responding to PDE5 Inhibitors (LI-ESWT)
Condition: Erectile Dysfunction
Interventions: Device: Omnispec model ED1000;   Device: Sham control
Outcome Measures: Increase in IIEF ED Domain Questionaire of >5 is considered as a treatment success;   Rigidity Score Questionaire- an increase of at least 1 point is considered as a treatment success
11 Not yet recruiting Effect of Functional Electrical Stimulation on Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Device: Functional Electrical Stimulation (FES);   Device: FES- Sham
Outcome Measure: Erectile function with International Index of Erectile Function-5 questionnaire
12 Unknown  Extracorporeal Shock Wave Therapy With a Wide Focus Probe for the Treatment of Erectile Dysfunction
Condition: Erectile Dysfunction
Intervention: Device: Low intensity shock waves
Outcome Measures: Change in IIEF-ED Domain Questionaire Score > 5 points is considered treatment success;   Rigidity Score Questionaire- an increase by at least 1 point is considered success
13 Unknown  Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction
Conditions: Prostate Cancer;   Erectile Dysfunction
Intervention: Biological: injection of bone marrow mononucleated cells
Outcome Measures: Absence of serious adverse event (general or local);   Recovery of natural erection, improvement of penile doppler parameters
14 Unknown  A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury
Condition: Erectile Dysfunction
Interventions: Drug: Vardenafil;   Drug: Placebo
Outcome Measures: EF domain score of IIEF;   IIEF/SEP/GAQ
15 Recruiting Sagene 2014 - Parkinson's Disease and Erectile Dysfunction
Conditions: Parkinson's Disease;   Erectile Dysfunction
Interventions: Drug: Selegiline;   Drug: Tadalafil
Outcome Measure: Changes in International Index of Erectile Function-5 (IIEF-5) score between baseline (Week 8) to end-of-study (Week 16).
16 Recruiting The Early Diagnosis and Warning Role of Erectile Dysfunction
Conditions: Erectile Dysfunction;   Endothelial Dysfunction
Intervention:
Outcome Measure:
17 Recruiting A Study of Tadalafil (LY450190) in Chinese Men With Erectile Dysfunction
Condition: Erectile Dysfunction
Intervention: Drug: Tadalafil
Outcome Measures: Proportion of Participants Experiencing at Least One Treatment Emergent Adverse Event (Serious or Non-Serious);   Change from Baseline in the International Index of Erectile Function- Erectile Function (IIEF-EF) Domain Questionnaire Score of 2.5 Milligrams (mg) Tadalafil;   Change from Baseline in the IIEF-EF Domain Questionnaire Score of 5 mg Tadalafil;   Change from Baseline in the IIEF-EF Domain Questionnaire Score of 5 mg Tadalafil Treatments;   Proportion of Participants with "Yes" Responses to Sexual Encounter Profile (SEP) Diary of 2.5 mg Tadalafil;   Proportion of Participants with "Yes" Responses to SEP Diary of 5 mg Tadalafil;   Proportion of Participants Achieving Normal Erectile Functioning of 2.5 mg Tadalafil;   Proportion of Participants Achieving Normal Erectile Functioning of 5 mg Tadalafil;   Proportion of Participants Achieving Normal Erectile Functioning of 5 mg Tadalafil Treatments;   Proportion of Participants with "Yes" Responses to GAQ1 and GAQ2 of 5 mg Tadalafil;   Proportion of Participants with "Yes" Responses to GAQ1 and GAQ2 of 5 mg Tadalafil Treatments
18 Unknown  Low Intensity Extracorporeal Shock Wave Therapy for the Treatment of Erectile Dysfunction- 4 Arms
Condition: Erectile Dysfunction
Intervention: Device: Extracorporeal Shockwave Therapy Generator (Omnispec ED1000)
Outcome Measures: Increase in IIEF ED Domain Questionaire of >5 is considered as a treatment success;   Rigidity Score Questionaire- an increase of at least 1 point is considered as a treatment success
19 Recruiting A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)
Conditions: Prostatic Hyperplasia;   Erectile Dysfunction
Interventions: Drug: 5 mg Tadalafil;   Drug: Placebo;   Drug: 0.2 mg Tamsulosin
Outcome Measures: Change from Baseline in Total International Prostate Symptom Score (IPSS) at Week 12;   Change from Baseline in International Index of Erectile Function (IIEF) Erectile Function (EF) Domain at Week 12;   Change From Baseline in Yes Responses to Question 2 of the Sexual Encounter Profile (SEP) Questionnaire at Week 12;   Change From Baseline in Yes Responses to Question 3 of the SEP Questionnaire at Week 12;   Change from Baseline in IPSS at Week 12;   Change from Baseline in Uroflowmetry Measures at Week 12;   Change from Baseline in Postvoid Residual Volume (PVR) at Week 12;   Change from Baseline in IPSS Storage (Irritative) Subscore at Week 12;   Change from Baseline in IPSS Voiding (Obstructive) Subscore at Week 12;   Change from Baseline in IPSS Quality of Life (QoL) Index at Week 12;   Patient Global Impression of Improvement (PGI-I) at Week 12;   Clinician Global Impression of Improvement (CGI-I) at Week 12;   Change from Baseline in IIEF Overall Satisfaction at Week 12;   Change from Baseline in IIEF Intercourse Satisfaction at Week 12;   Change from Baseline in IIEF Orgasmic Function at Week 12;   Change from Baseline in IIEF Sexual Desire at Week 12;   Change from Baseline in IIEF Subscores at Week 12;   Change from Baseline in Total IPSS at Week 4 and Week 8;   Change from Baseline in IIEF EF at Week 4 and Week 8;   Change From Baseline in Yes Responses to Question 2 of the SEP Questionnaire at Week 4 and Week 8;   Change From Baseline in Yes Responses to Question 3 of the SEP Questionnaire at Week 4 and Week 8;   Change from Baseline in modified IPSS at Week 2
20 Recruiting Early Intervention for Erectile Dysfunction After Laparoscopic Resection for Rectal Cancer
Conditions: Rectal Tumors;   Erectile Dysfunction
Intervention: Other: vacuum erection device
Outcome Measures: Changes in sexual function based on the (IIEF)-5 score and NPT;   Compliance and overall patient satisfaction based on the self reported compliance diary and IIEF-5 score and NPT

These studies may lead to new treatments and are adding insight into Erectile Dysfunction etiology and treatment.

A major focus of Erectile Dysfunction research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.


Discuss Erectile Dysfunction